Valuation : DiaSorin S.p.A.

Market Cap 3.73B 4.33B 3.51B 3.2B 5.99B 409B 6.01B 41.47B 16.08B 210B 16.26B 15.91B 677B P/E 2026 *
21.8x
P/E 2027 * 19.3x
Enterprise Value 4.44B 5.15B 4.17B 3.81B 7.13B 487B 7.15B 49.33B 19.12B 250B 19.35B 18.92B 805B EV / Sales 2026 *
3.59x
EV / Sales 2027 * 3.26x
Free-Float
37.17%
Yield 2026 *
1.73%
Yield 2027 * 1.81%
1 day-1.82%
1 week-1.64%
Current month-0.69%
1 month+0.59%
3 months+5.52%
6 months+9.66%
Current year+9.82%
1 week 74.44
Extreme 74.44
77.4
1 month 72.84
Extreme 72.84
77.5
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
82.96
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 2007-03-25
Director of Finance/CFO - 2024-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 2016-04-27
Director/Board Member 63 2007-03-25
Chairman 57 2022-04-28
Date Insider Type Main position Quantity % Market Cap. Importance
3/24/26 Buy

Chief Executive Officer

9,211 0.0165%
1/28/26 Buy

Chief Executive Officer

7,500 0.0134%
1/8/26 Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-1.82%-1.64%-8.48%-20.67% 4.33B
+0.23%-0.06%+168.44%+357.12% 21.66B
-2.24%-1.33%-37.24%-20.96% 10.16B
-0.90%+1.80%+348.78%+19.38% 8.16B
-0.99%-2.18%-28.06% - 7.08B
-0.01%+0.20%+84.42%+52.87% 6.59B
+2.34%-1.27%-20.74%-15.41% 6.03B
-0.62%-0.38%+74.99%+85.77% 4.22B
+1.82%-0.27%-18.67%-28.71% 2.81B
+2.23%+6.01% - - 1.39B
Average +0.00%+0.22%+62.60%+53.67% 7.24B
Weighted average by Cap. -0.28%-0.14%+92.58%+127.08%

Financials

2026 *2027 *
Net sales 1.23B 1.43B 1.16B 1.06B 1.98B 135B 1.99B 13.72B 5.32B 69.48B 5.38B 5.26B 224B 1.31B 1.52B 1.23B 1.13B 2.11B 144B 2.11B 14.57B 5.65B 73.76B 5.71B 5.59B 238B
Net income 183M 213M 172M 157M 294M 20.09B 295M 2.03B 789M 10.3B 798M 781M 33.2B 206M 239M 193M 177M 330M 22.56B 331M 2.29B 886M 11.57B 896M 877M 37.3B
Net Debt 707M 821M 665M 607M 1.14B 77.54B 1.14B 7.86B 3.05B 39.77B 3.08B 3.01B 128B 542M 629M 510M 466M 871M 59.47B 873M 6.03B 2.34B 30.5B 2.36B 2.31B 98.3B
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
26-09-04 €75.36 -1.82% 122,938
26-09-03 €76.76 +0.50% 126,349
26-09-02 €76.38 +0.71% 211,681
26-09-01 €75.84 -0.05% 190,146
26-08-31 €75.88 -0.97% 287,642
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
75.36EUR
Average target price
71.66EUR
Spread / Average Target
-4.90%

Quarterly revenue - Rate of surprise